Recombinant Human Erythropoietin as an Alternative to Blood Transfusion in Cancer-Related Anaemia
- 1 November 2000
- journal article
- Published by Springer Nature in Disease Management and Health Outcomes
- Vol. 8 (5), 259-272
- https://doi.org/10.2165/00115677-200008050-00002
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Transfusion-Induced Immunomodulation Following Cancer Surgery: Fact or Fiction?JNCI Journal of the National Cancer Institute, 1998
- New epidemiologic leads in the etiology of non-Hodgkin lymphoma in the elderly: the role of blood transfusion and dietBiomedicine & Pharmacotherapy, 1997
- Transfusion-related bacterial sepsisCurrent Opinion in Hematology, 1997
- TREATING ANEMIAHematology/Oncology Clinics of North America, 1996
- TRANSFUSION AND STEM CELL SUPPORT IN CANCER TREATMENTHematology/Oncology Clinics of North America, 1996
- Platelet transfusion support for patients with cancer and hematologic malignanciesCurrent Opinion in Hematology, 1996
- Prevalence of Bacterial Contamination in Whole Blood after DonationVox Sanguinis, 1995
- The role of cytokines in blood transfusion reactionsBlood Reviews, 1995
- Methods for the reduction of transfusion‐transmitted cytomegalovirus infection: filtration versus the use of seronegative donor unitsTransfusion, 1994
- Decreased Erythropoietin Response in Patients with the Anemia of CancerNew England Journal of Medicine, 1990